Published January 1, 2022
| Version v1
Journal article
Open
beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene
- 1. Yuzuncu Yil Univ, Fac Med, Dept Med Biol, TR-65090 Van, Turkey
Description
Background The c-myc oncogene, which causes glutamine dependence in triple negative breast cancers (TNBC), is also the target of one of the signaling pathways affected by beta-Escin.
Files
bib-16862ca1-04e0-4a2e-b481-66f7da88c975.txt
Files
(242 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:84fb86e6072cf08163d30e88341cdf7e
|
242 Bytes | Preview Download |